Literature DB >> 11566324

Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries.

S D Nuttall1, U V Krishnan, M Hattarki, R De Gori, R A Irving, P J Hudson.   

Abstract

The new antigen receptor (NAR) from nurse sharks consists of an immunoglobulin variable domain attached to five constant domains, and is hypothesised to function as an antigen-binding antibody-like molecule. To determine whether the NAR is present in other species we have isolated a number of new antigen receptor variable domains from the spotted wobbegong shark (Orectolobus maculatus) and compared their structure to that of the nurse shark protein. To determine whether these wNARs can function as antigen-binding proteins, we have used them as scaffolds for the construction of protein libraries in which the CDR3 loop was randomised, and displayed the resulting recombinant domains on the surface of fd bacteriophages. On selection against several protein antigens, the highest affinity wNAR proteins were generated against the Gingipain K protease from Porphyromonas gingivalis. One wNAR protein bound Gingipain K specifically by ELISA and BIAcore analysis and, when expressed in E. coli and purified by affinity chromatography, eluted from an FPLC column as a single peak consistent with folding into a monomeric protein. Naturally occurring nurse shark and wobbegong NAR variable domains exhibit conserved cysteine residues within the CDR1 and CDR3 loops which potentially form disulphide linkages and enhance protein stability; proteins isolated from the in vitro NAR wobbegong library showed similar selection for such paired cysteine residues. Thus, the New Antigen Receptor represents a protein scaffold with possible stability advantages over conventional antibodies when used in in vitro molecular libraries.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566324     DOI: 10.1016/s0161-5890(01)00057-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  36 in total

Review 1.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

2.  Structural evidence for evolution of shark Ig new antigen receptor variable domain antibodies from a cell-surface receptor.

Authors:  V A Streltsov; J N Varghese; J A Carmichael; R A Irving; P J Hudson; S D Nuttall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-10       Impact factor: 11.205

3.  Structure of a shark IgNAR antibody variable domain and modeling of an early-developmental isotype.

Authors:  Victor A Streltsov; Jennifer A Carmichael; Stewart D Nuttall
Journal:  Protein Sci       Date:  2005-09-30       Impact factor: 6.725

Review 4.  A new generation of protein display scaffolds for molecular recognition.

Authors:  Ralf J Hosse; Achim Rothe; Barbara E Power
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

5.  Protocol for the selection of single-domain antibody fragments by third generation intracellular antibody capture.

Authors:  Tomoyuki Tanaka; Terence H Rabbitts
Journal:  Nat Protoc       Date:  2009-12-17       Impact factor: 13.491

6.  Isolation of rabbit single domain antibodies to B7-H3 via protein immunization and phage display.

Authors:  Ruonan Feng; Ruixue Wang; Jessica Hong; Christopher M Dower; Brad St Croix; Mitchell Ho
Journal:  Antib Ther       Date:  2020-02-17

Review 7.  Structural and genetic diversity in antibody repertoires from diverse species.

Authors:  Miguel de los Rios; Michael F Criscitiello; Vaughn V Smider
Journal:  Curr Opin Struct Biol       Date:  2015-07-17       Impact factor: 6.809

8.  Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain.

Authors:  Mischa R Müller; Kenneth Saunders; Christopher Grace; Macy Jin; Nicole Piche-Nicholas; John Steven; Ronan O'Dwyer; Leeying Wu; Lam Khetemenee; Yulia Vugmeyster; Timothy P Hickling; Lioudmila Tchistiakova; Stephane Olland; Davinder Gill; Allan Jensen; Caroline J Barelle
Journal:  MAbs       Date:  2012 Nov-Dec       Impact factor: 5.857

Review 9.  Single domain antibodies for the knockdown of cytosolic and nuclear proteins.

Authors:  Thomas Böldicke
Journal:  Protein Sci       Date:  2017-03-24       Impact factor: 6.725

10.  Human TNF cytokine neutralization with a vNAR from Heterodontus francisci shark: a potential therapeutic use.

Authors:  Tanya Camacho-Villegas; Teresa Mata-Gonzalez; Jorge Paniagua-Solis; Edna Sanchez; Alexei Licea
Journal:  MAbs       Date:  2012-12-05       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.